GT Medical Technologies: Pioneering a New Paradigm for Brain Tumor Radiotherapy

GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.

GammaTile Therapy

The 24 best medical device innovations of 2022

GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.